Discrimination of benign and malignant ovarian sex cord-stromal tumors through the analysis of clinical features, MR imaging, and MR-based radiomics - Scorecard - MDSpire
Advertisement
Discrimination of benign and malignant ovarian sex cord-stromal tumors through the analysis of clinical features, MR imaging, and MR-based radiomics
Clinical Scorecard: Differentiating Benign from Malignant Ovarian Sex Cord-Stromal Tumors Using Clinical Features, MRI, and Radiomic Analysis
At a Glance
Category
Detail
Condition
Key Mechanisms
Utilization of clinical parameters, conventional MRI, and radiomic signatures for differentiation.
Target Population
Care Setting
Key Highlights
Study involved 113 patients with 123 SCSTs (42 malignant, 81 benign).
Combined nomogram achieved optimal predictive performance with AUCs of 0.945 (95% CI: 0.892-0.985) in training and 0.914 (95% CI: 0.798-0.988) in validation cohorts.
Traditional model and MRI-based radiomics model showed significant potential for SCSTs stratification.
Guideline-Based Recommendations
Diagnosis
Use clinical parameters and MRI characteristics for preoperative identification of SCSTs.
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Younger women of reproductive age with SCSTs.
Personalized therapeutic management should be based on the combined nomogram.
Clinical Best Practices
Utilize MRI for evaluation of adnexal lesions.
Incorporate radiomic analysis to improve diagnostic accuracy.
